Log in
NYSE:BAX

Baxter International Stock Forecast, Price & News

$80.25
-2.72 (-3.28 %)
(As of 09/21/2020 12:00 AM ET)
Add
Compare
Today's Range
$79.24
Now: $80.25
$81.86
50-Day Range
$80.37
MA: $83.25
$87.07
52-Week Range
$69.10
Now: $80.25
$95.19
Volume2.72 million shs
Average Volume3.16 million shs
Market Capitalization$40.63 billion
P/E Ratio24.24
Dividend Yield1.18%
Beta0.79
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Read More
Baxter International logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.7Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.00 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP07181310
Phone224-948-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.36 billion
Cash Flow$4.81 per share
Book Value$15.50 per share

Profitability

Net Income$1.00 billion

Miscellaneous

Employees50,000
Market Cap$40.63 billion
Next Earnings Date10/29/2020 (Confirmed)
OptionableOptionable
$80.25
-2.72 (-3.28 %)
(As of 09/21/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BAX News and Ratings via Email

Sign-up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Baxter International (NYSE:BAX) Frequently Asked Questions

How has Baxter International's stock been impacted by Coronavirus?

Baxter International's stock was trading at $77.97 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BAX stock has increased by 2.9% and is now trading at $80.25.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Baxter International?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 5 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Baxter International
.

When is Baxter International's next earnings date?

Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, October 29th 2020.
View our earnings forecast for Baxter International
.

How can I listen to Baxter International's earnings call?

Baxter International will be holding an earnings conference call on Thursday, October 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Baxter International's earnings last quarter?

Baxter International Inc (NYSE:BAX) announced its quarterly earnings results on Thursday, July, 30th. The medical instruments supplier reported $0.64 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.71 by $0.07. The medical instruments supplier had revenue of $2.72 billion for the quarter, compared to the consensus estimate of $2.86 billion. Baxter International had a net margin of 8.10% and a return on equity of 20.75%. The firm's quarterly revenue was down 4.3% on a year-over-year basis. During the same period last year, the company posted $0.89 EPS.
View Baxter International's earnings history
.

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International declared a quarterly dividend on Tuesday, July 14th. Investors of record on Monday, August 31st will be paid a dividend of $0.245 per share on Thursday, October 1st. This represents a $0.98 annualized dividend and a dividend yield of 1.22%. The ex-dividend date is Friday, August 28th.
View Baxter International's dividend history
.

How will Baxter International's stock buyback program work?

Baxter International declared that its board has authorized a share repurchase program on Tuesday, November 13th 2018, which permits the company to buyback $2,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to repurchase up to 6.1% of its shares through open market purchases. Shares buyback programs are often a sign that the company's board of directors believes its stock is undervalued.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International updated its FY20 earnings guidance on Thursday, July, 30th. The company provided EPS guidance of $3.00-3.10 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.31. The company issued revenue guidance of (1%) - 1% to $11.6-11.8 billion, compared to the consensus revenue estimate of $11.71 billion.

What price target have analysts set for BAX?

18 equities research analysts have issued 1 year price objectives for Baxter International's shares. Their forecasts range from $84.00 to $105.00. On average, they anticipate Baxter International's share price to reach $96.94 in the next year. This suggests a possible upside of 20.8% from the stock's current price.
View analysts' price targets for Baxter International
.

Who are some of Baxter International's key competitors?

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Honeywell International (HON), Abbott Laboratories (ABT), Intel (INTC), Procter & Gamble (PG), Verizon Communications (VZ) and Home Depot (HD).

Who are Baxter International's key executives?

Baxter International's management team includes the following people:
  • Mr. José E. Almeida, Chairman, Pres & CEO (Age 57)
  • Mr. James K. Saccaro, Exec. VP & CFO (Age 46)
  • Mr. Sean Martin, Sr. VP & Gen. Counsel (Age 56)
  • Mr. Giuseppe Accogli, Sr. VP & Pres of Americas (Age 48)
  • Mr. Scott Pleau, Sr. VP of Operations (Age 53)

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Who are Baxter International's major shareholders?

Baxter International's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.80%), Vanguard Group Inc. (7.90%), FMR LLC (2.48%), Nuveen Asset Management LLC (1.07%), Bank of New York Mellon Corp (0.83%) and Third Point LLC (0.79%). Company insiders that own Baxter International stock include Albert P L Stroucken, Andrew Frye, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Sean Martin, Third Point Llc and Thomas T Stallkamp.
View institutional ownership trends for Baxter International
.

Which institutional investors are selling Baxter International stock?

BAX stock was sold by a variety of institutional investors in the last quarter, including Third Point LLC, Nuveen Asset Management LLC, FMR LLC, FIL Ltd, Point72 Asset Management L.P., Sumitomo Mitsui Trust Holdings Inc., Balyasny Asset Management LLC, and Toronto Dominion Bank. Company insiders that have sold Baxter International company stock in the last year include Albert P L Stroucken, Andrew Frye, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, and John D Forsyth.
View insider buying and selling activity for Baxter International
.

Which institutional investors are buying Baxter International stock?

BAX stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Two Sigma Advisers LP, Victory Capital Management Inc., Cincinnati Financial Corp, RTW Investments LP, Avidity Partners Management LP, Marshall Wace North America L.P., and Marshall Wace LLP.
View insider buying and selling activity for Baxter International
.

How do I buy shares of Baxter International?

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $80.25.

How big of a company is Baxter International?

Baxter International has a market capitalization of $40.63 billion and generates $11.36 billion in revenue each year. The medical instruments supplier earns $1.00 billion in net income (profit) each year or $3.31 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.

What is Baxter International's official website?

The official website for Baxter International is www.baxter.com.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at global_corp_inve[email protected]

This page was last updated on 9/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.